APRISO
mesalamine
- Strength
- 375 mg/1
- Form
- Capsule, Extended Release
- Class
- Aminosalicylate
Salix Pharmaceuticals, Inc.
Listed by ANI Pharmaceuticals, Inc.
| Dosage form | Enema |
|---|---|
| Route | Rectal |
| Drug class | Aminosalicylate |
| Approval route | Authorised generic |
| NDC code | 62559-420 |
| FDA application | NDA019618 |
| RxNorm concept | 238151 |
| Package sizes listed | 1 |
| Marketed since | May 2016 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
mesalamine
Salix Pharmaceuticals, Inc.
Mesalamine
Allergan, Inc.
mesalamine
Takeda Pharmaceuticals America, Inc.
Teva Pharmaceuticals USA, Inc.
American Health Packaging
Sun Pharmaceutical Industries Inc.
Sun Pharmaceutical Industries, Inc.
Zydus Pharmaceuticals USA Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.